Brussels, 20-6-2013 — /europawire.eu/ — The European Commission has imposed a fine of € 93,8 million on Danish pharmaceutical company Lundbeck and fines totalling € 52,2 million on several producers of generic medicines. In 2002, Lundbeck agreed with each of these … Read the full press release →
Posted in Belgium, Business, Denmark, European Union, Financial, Government, Healthcare, Law, Pharma & Biotech, Society
Tagged anticompetitive agreements, antidepressant medicine, ANTITRUST, blockbuster antidepressant, citalopram, citalopram molecule, EU antitrust rules, fine, generic medicines, Generics UK, Joaquin Almunia, lump sums, Lundbeck, medicines, Merck KGaA, Patents, pharmaceutical company, Ranbaxy, Zoetis